These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1346709)

  • 1. Screening for HIV p24 antigen.
    Contreras M; Barbara J
    Lancet; 1992 Feb; 339(8790):438-9. PubMed ID: 1346709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neopterin--a prognostic marker in HIV infection].
    Breustedt W; Rabe H; Volk D; Porstmann P
    Dermatol Monatsschr; 1989; 175(4):226-31. PubMed ID: 2499491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV p24 antigen test in blood donors].
    Wüllenweber J
    Med Klin (Munich); 1994 May; 89(5):286. PubMed ID: 8052186
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neopterin in human immunodeficiency virus (HIV) infection].
    Wachter H; Fuchs D; Hausen A; Reibnegger G; Werner ER; Dierich MP
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1890-7. PubMed ID: 3058449
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV antigen study].
    Reissigl H; Rosmanith P; Schönitzer D
    Beitr Infusionsther; 1989; 24():14-7. PubMed ID: 2481531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
    Busch MP; Taylor PE; Lenes BA; Kleinman SH; Stuart M; Stevens CE; Tomasulo PA; Allain JP; Hollingsworth CG; Mosley JW
    N Engl J Med; 1990 Nov; 323(19):1308-12. PubMed ID: 2120588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation on HIV serology and immune-stimulation on patients in Tanzania.
    Hengster P; Schmutzhard E; Fuchs D; Hofbauer J; Wachter H; Dierich MP
    Int J STD AIDS; 1991; 2(3):180-4. PubMed ID: 1907499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
    Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early confirmation of HIV p24 antigenaemia in infants born of HIV-positive mothers.
    Corbitt G
    J Infect; 1993 May; 26(3):349-51. PubMed ID: 8505582
    [No Abstract]   [Full Text] [Related]  

  • 11. trans-Activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro.
    Baier-Bitterlich G; Fuchs D; Zangerle R; Baeuerle PA; Werner ER; Fresser F; Uberall F; Baier G; Wachter H
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):173-8. PubMed ID: 9007202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
    Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I soluble antigen serum levels in HIV-positive subjects--correlation with cellular and serological parameters.
    Puppo F; Orlandini A; Ruzzenenti R; Comuzio S; Salamito A; Farinelli A; Stagnaro R; Indiveri F
    Cancer Detect Prev; 1990; 14(3):321-3. PubMed ID: 2117484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum beta 2-microglobulin in HIV infection.
    Krämer A; Goedert JJ; Wachter H; Fuchs D
    Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting who will progress to AIDS.
    Moss AR
    BMJ; 1988 Oct; 297(6656):1067-8. PubMed ID: 2973821
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI).
    Reddy MM; McKinley GF; Grieco MH
    J Clin Lab Anal; 1991; 5(6):396-8. PubMed ID: 1774603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
    Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
    Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p24 antigen and HIV screening.
    Lefrère JJ; Courouce AM; Rouger P; Duedari N; Elghouzzi MH
    Lancet; 1992 Apr; 339(8799):999-1000. PubMed ID: 1348838
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and therapeutic technology assessment. Surrogate markers of progressive HIV disease.
    JAMA; 1992 Jun; 267(21):2948-52. PubMed ID: 1349928
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.
    Crocchiolo PR; Lizioli A; Cantaluppi P; Filippi C; D'Agostino F; Cambié G; Panzeri MP; Nardella ML
    J Clin Lab Immunol; 1990 Feb; 31(2):55-7. PubMed ID: 1983767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.